CD19 expression and growth inhibition of tumours in human multiple myeloma

Leukemia and Lymphoma

Volumn 43, Issue 3, 2002, Pages 613-616

  Ishikawa, Hideaki ^a   Tsuyama, Naohiro ^a   Mahmoud, Maged S ^a   Fujii, Ryuichi ^a   Abroun, Saeid ^a   Liu, Shangqin ^a   Li, Fu Jun ^a   Kawano, Michio M ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

CD19; Growth inhibition; Multiple myeloma; Plasma cells

Indexed keywords

CD19 ANTIGEN; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CARCINOGENICITY; CELL CLONE; CELL ISOLATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CYTOPLASM; DRUG TARGETING; GENE EXPRESSION; GENE THERAPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MUTANT; MYELOMA CELL; PHENOTYPE; PLASMA CELL; PRECANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANTIGENS, CD19; CELL DIVISION; HUMANS; MULTIPLE MYELOMA; PLASMA CELLS;

EID: 0036122583     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290012146     Document Type: Article

References (27)

1. "Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas"
2. "Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice"
3. "Interleukin 6 is essential for in vivo development of B lineage neoplasms"
4. "Defective development of pristine-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice"
5. "The CD19/CD21 signal transduction complex of B lymphocytes"
6. "Phenotypic difference of normal plasma cells from mature myeloma cells"
7. "Altered expression of Pax-5 gene in human myeloma cells"
8. "Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity"
9. "Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule"
10. "Expression of Leu-19 (NKH-1) antigen on IL-2-dependent cytotoxic and non-cytotoxic T cell lines"
11. "Intersection of the complement and immune systems: A signal transduction complex of the B lymphocyte containing complement receptor type 2 and CD19"
12. "The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody and Leu-13 molecules"
13. "Expression of human B cell-associated antigens on leukemias and lymphomas: A model of human B cell differentiation"
14. "Expression of cell surface markers after human B lymphocyte activation"
15. "Monoclonal gammopathies of undetermined significances"
16. "The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP"
17. "Pax in development"
18. "Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax-5/BSAP"
19. "CD19 regulation of human B cell responses: B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used"
20. "CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes"
21. "Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice"
22. "Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19"
23. "The CD19 complex of B lymphocytes: Activation of phospholipase C by a protein kinase-dependent pathway that can be enhanced by the membrane IgM complex"
24. "CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase"
25. "Cd19 as a membrane-anchored adaptor protein of B lymphocytes: Costimulation of lipid and protein kinases by recruitment of Vav"
26. "CD19 regulates src family protein tyrosine kinase activation in B lymphocytes through processive amplification"
27. 2+ mobilization"